← FDA Drug Approvals (Drugs@FDA)

INPEFA

NDA · New Drug Application · Sponsor: LEXICON PHARMS INC · Approved 2023-05-26

Drug application

FDA Application #

NDA216203

Application type

New Drug Application

Brand name

INPEFA

Generic name

SOTAGLIFLOZIN

Active ingredients

SOTAGLIFLOZIN

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

LEXICON PHARMS INC

Manufacturer

Lexicon Pharmaceuticals, Inc.

First approval

2023-05-26

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown